PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
Basic information |
| Metabolite name | PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
 | HMDB0009144 |
 |
C00350 |
 |
52924410 |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| HMDB0009144 |
|
C00350 |
|
52924410 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1098 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1098 | Type2 | CUMS + L-theanine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |